Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Comparison of the MFI of expression of p24 in CD4+ T cells following contact of virions with calcitriol: or EtOH-treated End1 (B), Ect1 (D) or Vk2 monolayers (F).

Source: Vitamin D: conditioned female reproductive tract epithelial cells directly attenuate HIV-1 virion infectivity. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Laboratory / cell research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Endocervical (End1), ectocervical (Ect1) and vaginal (Vk2) epithelial cell lines were cultured in transwells and treated for 24 hours with VitD (1x10-8M).

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D boosts HIV-1 resistance in female genital epithelial cells by enhancing antiviral cathelicidin expression

Study design awaiting verification · Frontiers in Immunology · 2026

Original publication title

Vitamin D boosts HIV-1 resistance in female genital epithelial cells by enhancing antiviral cathelicidin expression

Sandra M. Gonzalez; Wbeimar Aguilar-Jimenez; Maria T. Rugeles; Abu Bakar Siddik; Erica Hofer Labossiere; T. Blake Ball; Ruey-Chyi Su

Copyright © 2026 Gonzalez, Aguilar-Jimenez, Rugeles, Siddik, Labossiere, Ball and Su.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

These findings provide evidence that VitD enhances the antiviral properties of female genital epithelium and reduces HIV-1 infectivity.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Elevated levels of serum Vitamin D (VitD) and increased expression of its receptor on peripheral blood cells have been reported in individuals who have been exposed to HIV-1 yet remain seronegative (HESN). This study aimed to investigate the potential antiviral role of VitD in the female genital epithelium, which constitutes the first physical barrier against HIV-1. We hypothesized that VitD may modulate susceptibility to HIV-1 infection by influencing epithelial functions such as tight junction integrity, production of antiviral peptides, and secretion of pro-inflammatory mediators.

Source: Introduction

Abstract: What methods does the paper describe?

Endocervical (End1), ectocervical (Ect1) and vaginal (Vk2) epithelial cell lines were cultured in transwells and treated for 24 hours with VitD (1x10-8M). After VitD removal, HIV-1 were added to the apical chamber, and CD4+ T cells (HIV targets) were placed in the basal chamber. HIV-1 transmigration and infection of CD4+ T cells were quantified. CAMP (cathelicidin) transcript levels and protein secretion were also measured.

Source: Methods

Abstract: Results

Pre-treatment of End1, Ect1 and Vk2 epithelial monolayers with VitD reduced HIV-infection of the CD4+ T cells in the basal chamber by 50%, 53%, and 31%, respectively. Only a fraction of the HIV-1 virion applied apically transmigrated across the epithelium. The infectivity of the residual apical HIV-1 virion in the VitD-pre-treated End1, Ect1, and VK2 cultures was reduced by 42%, 36%, and 25%, respectively. These reductions were accompanied by increased RNA transcripts encoding Cathelicidin Antimicrobial Peptide (CAMP) and elevated secretion of CAMP protein into the apical chamber.

Source: Results

Abstract: Conclusion

These findings provide evidence that VitD enhances the antiviral properties of female genital epithelium and reduces HIV-1 infectivity.

Source: Conclusion
Authors’ abstract

Introduction

Elevated levels of serum Vitamin D (VitD) and increased expression of its receptor on peripheral blood cells have been reported in individuals who have been exposed to HIV-1 yet remain seronegative (HESN). This study aimed to investigate the potential antiviral role of VitD in the female genital epithelium, which constitutes the first physical barrier against HIV-1. We hypothesized that VitD may modulate susceptibility to HIV-1 infection by influencing epithelial functions such as tight junction integrity, production of antiviral peptides, and secretion of pro-inflammatory mediators.

Methods

Endocervical (End1), ectocervical (Ect1) and vaginal (Vk2) epithelial cell lines were cultured in transwells and treated for 24 hours with VitD (1x10-8M). After VitD removal, HIV-1 were added to the apical chamber, and CD4+ T cells (HIV targets) were placed in the basal chamber. HIV-1 transmigration and infection of CD4+ T cells were quantified. CAMP (cathelicidin) transcript levels and protein secretion were also measured.

Results

Pre-treatment of End1, Ect1 and Vk2 epithelial monolayers with VitD reduced HIV-infection of the CD4+ T cells in the basal chamber by 50%, 53%, and 31%, respectively. Only a fraction of the HIV-1 virion applied apically transmigrated across the epithelium. The infectivity of the residual apical HIV-1 virion in the VitD-pre-treated End1, Ect1, and VK2 cultures was reduced by 42%, 36%, and 25%, respectively. These reductions were accompanied by increased RNA transcripts encoding Cathelicidin Antimicrobial Peptide (CAMP) and elevated secretion of CAMP protein into the apical chamber.

Conclusion

These findings provide evidence that VitD enhances the antiviral properties of female genital epithelium and reduces HIV-1 infectivity.

Publication and source details

Original title: Vitamin D boosts HIV-1 resistance in female genital epithelial cells by enhancing antiviral cathelicidin expression

Sandra M. Gonzalez; Wbeimar Aguilar-Jimenez; Maria T. Rugeles; Abu Bakar Siddik; Erica Hofer Labossiere; T. Blake Ball; Ruey-Chyi Su

Frontiers in Immunology · 2026

* Correspondence: Sandra M. Gonzalez, Sandra.gonzalezdiaz@umanitoba.caCopyright © 2026 Gonzalez, Aguilar-Jimenez, Rugeles, Siddik, Labossiere, Ball and Su.2026Gonzalez, Aguilar-Jimenez, Rugeles, Siddik, Labossiere, Ball and Suhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This research was funded by Universidad de Antioquia, UdeA and COLCIENCIAS (Code 111565740508 and Code 111574455024), CIHR project grant, grant number 154043 (to TB & R-CS) and operating funds to (R-CS & TB) by the STBBI division, NML, PHAC. SG is a recipient of a doctoral scholarship from Colciencias (647-2014) and the ELAP program scholarship Canada. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T16:24:54.974284+00:00

DOI: 10.3389/fimmu.2026.1758656 · PMC13132785